SM
ISEE

Sabby Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Sabby Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-133
Closed -$16K – 140
2018
Q4 		$16K Hold
133
– – ﹤0.01% 111
2018
Q3 		$31K Hold
133
– – ﹤0.01% 115
2018
Q2 		$36K Buy
+133
New +$367 0.01% 123
2014
Q2 		– Sell
-400
Closed -$1.43M – 295
2014
Q1 		$1.43M Buy
+400
New +$13.5K 0.08% 124

Other funds holding ISEE

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Sabby Management's ISEE Position: Q1 2019 in Review

Sabby Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2019, closing a stake of 2,037,460 shares — an estimated $2.44M sold.

Sabby Management first reported a position in ISEE in Q1 2014 and held it in 4 quarters. The position peaked at $3.82M in Q3 2018. 58 funds tracked by Wall St. Rank hold ISEE as of Q1 2019.

  • Sabby Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Sabby Management sold 2,037,460 IVERIC bio, Inc. Common Stock shares in Q1 2019, an estimated $2.44M.
  • Sabby Management first reported a position in IVERIC bio, Inc. Common Stock in Q1 2014 and held it in 4 quarters.
  • Sabby Management's IVERIC bio, Inc. Common Stock position peaked at $3.82M in Q3 2018.
  • 58 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2019.

Based on Sabby Management's 13F filing for Q1 2019, filed 15 May 2019.